Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Barry Greene
Age : 56
Public asset : 16,803,011 USD
Country of residence : Unknown
Linked companies : Sage Therapeutics, Inc. - Karyopharm Therapeutics Inc. - BCLS Acquisition Corp.

Biography of Barry Greene 
Dr. Barry E. Greene, MD, is an Independent Director at BCLS Acquisition Corp., a President, Chief Executive Officer & Director at SAGE Therapeutics, Inc., a Chief Medical Officer at Vicarious Surgical, Inc., a Lead Independent Director at Karyopharm Therapeutics, Inc. and an Independent Director at Acorda Therapeutics, Inc. He is on the Board of Directors at BCLS Acquisition Corp., SAGE Therapeutics, Inc., Karyopharm Therapeutics, Inc. and Acorda Therapeutics, Inc. Dr. Greene was previously employed as an Independent Director by Ambrx, Inc., a President by Alnylam Pharmaceuticals, Inc., a General Manager-Oncology Division by Takeda Oncology Co., a Vice President-Marketing & Customer Services by AstraZeneca Plc, a Partner by Andersen Consulting LLP (GB), a Partner by Accenture Ltd., a Vice President-Strategic Integration by AstraZeneca Pharmaceuticals LP, and a Chief Business Officer & Executive Vice President by Mediconsult.com, Inc. He also served on the board at Intercept Pharmaceuticals, Inc. and Regulus Therapeutics, Inc. He received his undergraduate degree from the University of Pittsburgh.


Current positions of Barry Greene 
Holdings of Barry Greene 
Barry Greene : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Barry Greene : Connections 


Latest news about Barry Greene 
09/17Vicarious Surgical Inc. completed the acquisition of D8 Holdings Corp. in a reverse merger transaction.
CI
08/23Acorda Therapeutics, Inc. Announces Board Resignations
CI
04/15Vicarious Surgical Inc. entered into an agreement to acquire D8 Holdings Corp. for approximately $870 million in a reverse merger transaction.
CI
03/17SAGE THERAPEUTICS : Reports Positive Data in Study of Depressive Disorder Drug Zuranolone
MT
03/16SAGE THERAPEUTICS : CFO to Step Down
MT
03/05TRU Precious Metals Corp. announced that it has received CAD 3.500212 million in funding from Palisades Goldcorp Ltd., and other investors
CI
2020TRU Precious Metals Corp. Announces Management Changes
CI
More news